These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 32539131)
41. SKP2, positively regulated by circ_ODC1/miR-422a axis, promotes the proliferation of retinoblastoma. Du S; Wang S; Zhang F; Lv Y J Cell Biochem; 2020 Jan; 121(1):322-331. PubMed ID: 31297892 [TBL] [Abstract][Full Text] [Related]
42. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma. Wu N; Chen S; Luo Q; Jiang Z; Wang X; Li Y; Qiu J; Yu K; Yang Y; Zhuang J Exp Eye Res; 2022 Mar; 216():108955. PubMed ID: 35074341 [TBL] [Abstract][Full Text] [Related]
43. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma. Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266 [TBL] [Abstract][Full Text] [Related]
44. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120 [TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. Zhang S; Long J; Hu Y Biochem Biophys Res Commun; 2020 May; 526(2):396-403. PubMed ID: 32223925 [TBL] [Abstract][Full Text] [Related]
46. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1). Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314 [TBL] [Abstract][Full Text] [Related]
47. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p. Wu XZ; Cui HP; Lv HJ; Feng L Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143 [TBL] [Abstract][Full Text] [Related]
48. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884 [TBL] [Abstract][Full Text] [Related]
49. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597 [TBL] [Abstract][Full Text] [Related]
50. Differentially expressed miRNAs in retinoblastoma. Martin J; Bryar P; Mets M; Weinstein J; Jones A; Martin A; Vanin EF; Scholtens D; Costa FF; Soares MB; Laurie NA Gene; 2013 Jan; 512(2):294-9. PubMed ID: 23103829 [TBL] [Abstract][Full Text] [Related]
51. Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway. Zeng Z; Gao ZL; Zhang ZP; Jiang HB; Yang CQ; Yang J; Xia XB Int J Mol Med; 2019 Jul; 44(1):103-114. PubMed ID: 31115482 [TBL] [Abstract][Full Text] [Related]
52. MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8. Liu B; Lu B; Wang X; Jiang H; Kuang W Childs Nerv Syst; 2019 Aug; 35(8):1303-1311. PubMed ID: 31161266 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of microRNA‑492 attenuates cell proliferation and invasion in retinoblastoma via directly targeting LATS2. Sun Z; Zhang A; Zhang L Mol Med Rep; 2019 Mar; 19(3):1965-1971. PubMed ID: 30592270 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-486-5p inhibits ovarian granulosa cell proliferation and participates in the development of PCOS via targeting MST4. Han XM; Tian PY; Zhang JL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7217-7223. PubMed ID: 31539108 [TBL] [Abstract][Full Text] [Related]
55. miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3. Miao X; Wang Z; Chen B; Chen Y; Wang X; Jiang L; Jiang S; Hao K; Zhang W Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):42-47. PubMed ID: 29808799 [TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA Dong Y; Wan G; Yan P; Qian C; Li F; Peng G Aging (Albany NY); 2020 May; 12(9):7729-7746. PubMed ID: 32369777 [TBL] [Abstract][Full Text] [Related]
57. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations. Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway. Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233 [TBL] [Abstract][Full Text] [Related]
59. Impact of RARα and miR-138 on retinoblastoma etoposide resistance. Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126 [TBL] [Abstract][Full Text] [Related]
60. SP1-induced upregulation of lncRNA PANDAR predicts adverse phenotypes in retinoblastoma and regulates cell growth and apoptosis in vitro and in vivo. Sheng L; Wu J; Gong X; Dong D; Sun X Gene; 2018 Aug; 668():140-145. PubMed ID: 29778422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]